Department of Mental Health, Parc Taulí Hospital Universitari, Institut d'Investigació Sanitària Parc Taulí (I3PT), Translational Neuroscience Unit, Universitat Autònoma de Barcelona, CIBERSAM, Sabadell, Barcelona, Spain.
Hospital Universitari Institut Pere Mata, Institut d'Investigació Sanitària Pere Virgili (IISPV), Universitat Rovira i Virgili, CIBERSAM, Reus, Tarragona, Spain.
Early Interv Psychiatry. 2020 Aug;14(4):470-475. doi: 10.1111/eip.12873. Epub 2019 Sep 16.
In the current cross-sectional study, we aimed to explore whether thyroid function or thyroid autoimmunity are associated with psychopathological symptoms and social functioning in patients with early psychosis. We hypothesized that psychopathological severity is greater in those patients with positive thyroid autoimmunity.
We studied 70 outpatients with early psychosis (<3 years of illness) and 37 healthy subjects. Psychopathological symptoms (positive, negative, disorganized, excited and depressive) and social functioning were assessed. Thyroid autoimmunity (antibodies against thyroid peroxidase [TPO-Abs] and thyroglobulin [TG-Abs]) and thyroid function (thyroid-stimulating hormone [TSH] and free thyroxin [FT4]) were determined. Associations of thyroid variables and psychometric measures were assessed with Spearman's correlations. Logistic regression was performed to explore the association between psychopathological symptoms and positive anti-thyroidal antibodies while adjusting for covariates.
When compared to patients without thyroid antibodies, those with positive thyroid antibodies had more negative symptoms and poorer function (P < .05). Titres of TPO-Abs were significantly correlated with negative and depressive PANSS domains and poorer functioning. TG-Abs were also associated with poorer functioning but not with psychopathological symptoms. TSH and FT4 concentrations were not associated with clinical symptoms. In the logistic regression analysis adjusted for age, gender, antipsychotic treatment, lithium, TSH and FT4 concentrations, negative symptoms were associated with thyroid autoimmunity (OR = 1.2, P = .019).
Our study suggests that anti-thyroid antibodies are associated with a more severe phenotype with increased negative symptoms and poorer functioning in early psychotic patients. Since causality cannot be inferred with cross-sectional data, future longitudinal studies are needed to overcome this limitation.
在本横断面研究中,我们旨在探讨甲状腺功能或甲状腺自身免疫是否与早期精神病患者的精神病理学症状和社会功能有关。我们假设,具有阳性甲状腺自身免疫的患者的精神病理学严重程度更高。
我们研究了 70 名早期精神病(<3 年)患者和 37 名健康对照者。评估了精神病理学症状(阳性、阴性、紊乱、兴奋和抑郁)和社会功能。测定了甲状腺自身免疫(甲状腺过氧化物酶抗体[TPO-Abs]和甲状腺球蛋白抗体[TG-Abs])和甲状腺功能(促甲状腺激素[TSH]和游离甲状腺素[FT4])。使用 Spearman 相关分析评估了甲状腺变量与心理测量指标之间的关联。在调整协变量后,进行逻辑回归以探讨阳性抗甲状腺抗体与精神病理学症状之间的关联。
与无甲状腺抗体的患者相比,具有阳性甲状腺抗体的患者有更多的阴性症状和较差的功能(P<.05)。TPO-Abs 滴度与阴性和抑郁性 PANSS 域以及较差的功能显著相关。TG-Abs 也与较差的功能相关,但与精神病理学症状无关。TSH 和 FT4 浓度与临床症状无关。在调整年龄、性别、抗精神病药物治疗、锂、TSH 和 FT4 浓度后,逻辑回归分析显示,阴性症状与甲状腺自身免疫有关(OR=1.2,P=.019)。
我们的研究表明,抗甲状腺抗体与早期精神病患者的表型更严重相关,表现为更多的阴性症状和较差的功能。由于横断面数据无法推断因果关系,因此需要进行未来的纵向研究来克服这一局限性。